VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.09 and last traded at C$0.09, with a volume of 197364 shares trading hands. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Up 5.9 %
The stock has a market cap of C$14.60 million, a price-to-earnings ratio of -2.78 and a beta of 0.39. The business has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.14. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- Investing in Construction Stocks
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What Are the U.K. Market Holidays? How to Invest and Trade
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
